Author Correction: The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer

Ilenia Masi¹, Flavia Ottavi¹, Danila Del Rio¹, Valentina Caprara², Cristina Vastarelli¹, Sara Maria Giannitelli³, Giulia Fianco¹, Pamela Mozetic^{4

5}, Marianna Buttarelli^{6

7}, Gabriella Ferrandina^{6

7}, Giovanni Scambia^{6

7}, Daniela Gallo^{6

7}, Alberto Rainer^{3

4}, Anna Bagnato², Francesca Spadaro⁸, Laura Rosanò^{9

10}

Affiliations

¹ Institute of Molecular Biology and Pathology, CNR, Rome, 00185, Italy.
² Unit of Preclinical Models and New Therapeutic Agents, IRCCS-Regina Elena National Cancer Institute, Rome, 00144, Italy.
³ Department of Engineering, Università Campus Bio-Medico di Roma, via Álvaro del Portillo 21, Rome, 00128, Italy.
⁴ Institute of Nanotechnology (NANOTEC), National Research Council (CNR), c/o Campus Ecotekne, via Monteroni, Lecce, 73100, Italy.
⁵ San Raffaele Hospital, Division of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, Via Olgettina, 60, Milan, 20132, Italy.
⁶ Dipartimento Universitario Scienze della Vita e Sanità Pubblica-Sezione di Ginecologia ed Ostetricia-Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, Rome, 00168, Italy.
⁷ Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Largo A. Gemelli 8, Rome, 00168, Italy.
⁸ Confocal Microscopy Unit, Core Facilities, Istituto Superiore di Sanità, Rome, 00161, Italy.
⁹ Institute of Molecular Biology and Pathology, CNR, Rome, 00185, Italy. laura.rosano@cnr.it.
¹⁰ Unit of Preclinical Models and New Therapeutic Agents, IRCCS-Regina Elena National Cancer Institute, Rome, 00144, Italy. laura.rosano@cnr.it.

Published Erratum

Ilenia Masi et al. Cell Death Dis. 2024.

. 2024 Oct 21;15(10):766.

doi: 10.1038/s41419-024-07139-x.

¹ Institute of Molecular Biology and Pathology, CNR, Rome, 00185, Italy.
² Unit of Preclinical Models and New Therapeutic Agents, IRCCS-Regina Elena National Cancer Institute, Rome, 00144, Italy.
³ Department of Engineering, Università Campus Bio-Medico di Roma, via Álvaro del Portillo 21, Rome, 00128, Italy.
⁴ Institute of Nanotechnology (NANOTEC), National Research Council (CNR), c/o Campus Ecotekne, via Monteroni, Lecce, 73100, Italy.
⁵ San Raffaele Hospital, Division of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, Via Olgettina, 60, Milan, 20132, Italy.
⁶ Dipartimento Universitario Scienze della Vita e Sanità Pubblica-Sezione di Ginecologia ed Ostetricia-Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, Rome, 00168, Italy.
⁷ Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Largo A. Gemelli 8, Rome, 00168, Italy.
⁸ Confocal Microscopy Unit, Core Facilities, Istituto Superiore di Sanità, Rome, 00161, Italy.
⁹ Institute of Molecular Biology and Pathology, CNR, Rome, 00185, Italy. laura.rosano@cnr.it.
¹⁰ Unit of Preclinical Models and New Therapeutic Agents, IRCCS-Regina Elena National Cancer Institute, Rome, 00144, Italy. laura.rosano@cnr.it.

No abstract available

Erratum for

The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer.
Masi I, Ottavi F, Del Rio D, Caprara V, Vastarelli C, Giannitelli SM, Fianco G, Mozetic P, Buttarelli M, Ferrandina G, Scambia G, Gallo D, Rainer A, Bagnato A, Spadaro F, Rosanò L. Masi I, et al. Cell Death Dis. 2023 Jan 30;14(1):73. doi: 10.1038/s41419-023-05612-7. Cell Death Dis. 2023. PMID: 36717550 Free PMC article.